Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha

Table 1 Demographic and clinical characteristics of patients with chronic hepatitis C

Patient no.	Sex	Age	HCV GT*	Baseline HCV-RNA (copies/ml)	4 weeks HCV-RNA (copies/ml)	4-weeks response*	12 weeks HCV-RNA (copies/ml)	12-weeks response	Ribavirin (mg)	Weight, (Kg)	Type of peg IFN	AST	ALT	FOLLOW-UP
1	F	62	2a/2c	8224917	NEG	R	NEG	R	800	70	Alfa 2a	28	31	SVR
2	F	69	2	19948356	NEG	R	NEG	R	1000	78	Alfa 2a	28	30	SVR
3	F	39	2c	2748250	NEG	R	NEG	R	800	64	alfa 2a	30	38	SVR
4	F	51	2a/2c	4486254	NEG	R	NEG	R	1000	68	Alfa 2a	17	24	SVR
5	M	47	1b	1573026	6800	NR	NEG	R	1200	82	Alfa 2a	49	68	SVR
6	M	67	1a	6018477	21700	NR	NEG	R	1000	78	Alfa 2a	137	214	SVR
7	F	68	1b	941010	NEG	R	NEG	R	1000	74	Alfa 2a	25	54	SVR
8	M	47	2a/2c	3347068	445000	NR	937560	NR	1000	80	Alfa 2b	93	172	NR
9	M	49	2a	2859813	437000	NR	378000	NR	1000	84	Alfa 2b	110	115	NR
10	F	44	1a	2505703	17500	NR	327000	NR	1200	68	Alfa 2a	23	26	NR
11	F	66	1b	21967894	1200000	NR	2550	NR	800	51	Alfa 2a	44	80	NR
12	F	42	1a	1469947	161000	NR	16100	NR	1000	72	Alfa 2b	73	110	NR

*GT, genotype; R, responder, SVR, sustained viral responder; NR, non-responder; IFN, interferon; HCV, hepatitis C virus; AST, aspartate aminotransferase; ALT, alanine aminotransferase.

ISSN: 1743-422X